Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 301–315 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5831 GALNT3 Gene Genetic Test for Tumoral Calcinosis, Hyperphosphatemic, Familial, Type 1 This test identifies mutations within the GALNT3 gene associated with hyperphosphatemic familial tumoral calcinosis type 1.	Whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GALNT3 gene sequence", "Copy number variations in GALNT3"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed phosphate-lowering medications"] Indications ["Diagnosis of hyperphosphatemic familial tumoral calcinosis type 1", "Carrier screening", "Family testing"] Measurement technique Confirm with laboratory Codes LOINC: 82443-0 ICD-10: E83.51, E83.59 Clinical summary This test identifies mutations within the GALNT3 gene associated with hyperphosphatemic familial tumoral calcinosis type 1.
TEST-4520 GAN Gene (Giant Axonal Neuropathy Type 1) Genetic Test This genetic test analyzes the GAN gene for pathogenic variants associated with Giant Axonal Neuropathy type 1.	Whole Blood (EDTA) or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GAN gene", "Biallelic or monoallelic variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any anticoagulation medication"] Indications ["Suspected diagnosis of Giant Axonal Neuropathy type 1", "Family history of GAN1", "Differential diagnosis of progressive neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82810-3 ICD-10: G60.8 Clinical summary This genetic test analyzes the GAN gene for pathogenic variants associated with Giant Axonal Neuropathy type 1.
TEST-3354 GATA1 Gene Anemia, X-linked Genetic Test This test evaluates the GATA1 gene for pathogenic variants associated with X-linked dyserythropoietic anemia and thrombocytopenia.	Peripheral Whole Blood (2–5 mL) or FTA Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GATA1 gene", "Coding regions and splice sites"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (complete coding region coverage)"}] Preparation ["Genetic counseling is mandatory prior to sample collection.", "Do not discontinue prescribed medications without consulting your treating physician."] Indications ["Diagnostic confirmation of X-linked dyserythropoietic anemia", "Family cascade screening", "Guiding clinical management of hematologic manifestations"] Measurement technique Confirm with laboratory Codes LOINC: 51594-0 ICD-10: D64.8 Clinical summary This test evaluates the GATA1 gene for pathogenic variants associated with X-linked dyserythropoietic anemia and thrombocytopenia.
TEST-4130 GATA4 Gene Tetralogy of Fallot Genetic Test This test detects pathogenic variants in the GATA4 gene associated with Tetralogy of Fallot.	Whole Blood (Peripheral)	21 – 28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GATA4 gene pathogenic variants", "Point mutations", "Small indels", "Copy number variants (CNVs)"] Parameters [] Preparation [] Indications ["Confirmation of Tetralogy of Fallot diagnosis", "Assessment of familial recurrence risk", "Guidance for lifelong cardiac surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 94083-3 ICD-10: Q21.3 Clinical summary This test detects pathogenic variants in the GATA4 gene associated with Tetralogy of Fallot.
TEST-4397 GATA6 Gene Atrioventricular Septal Defect Type 5 NGS Test This test identifies genetic variants in the GATA6 gene associated with atrioventricular septal defect type 5 (AVSD5). It uses next-generation sequencing (NGS) for comprehensive an...	Whole blood (EDTA), extracted DNA, dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs) in GATA6 gene", "Insertions/deletions (indels) in GATA6 gene", "Copy number changes in GATA6 gene"] Parameters [] Preparation [] Indications ["Diagnosis confirmation of AVSD type 5", "Assessment of recurrence risk in families", "Guidance for surgical planning", "Identification of underlying genetic cause"] Measurement technique Confirm with laboratory Codes LOINC: 21561-4 ICD-10: Q21.2 Clinical summary This test identifies genetic variants in the GATA6 gene associated with atrioventricular septal defect type 5 (AVSD5). It uses next-generation sequencing (NGS) for comprehensive analysis.
TEST-4916 GATAD2B Gene Sequencing (Autosomal Dominant Intellectual Disability Type 18) NGS Test This diagnostic test evaluates the GATAD2B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 18 (MRD18).	Peripheral Whole Blood (EDTA tube) or Dried Blood Spot (FTA Card)	21 to 28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GATAD2B gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Small Copy Number Variants (CNVs)"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Suspected Autosomal Dominant Intellectual Disability Type 18 (MRD18)", "Unexplained intellectual disability with relevant clinical features", "Family history of MRD18"] Measurement technique Confirm with laboratory Codes LOINC: 94474-7 ICD-10: Q87.89 Clinical summary This diagnostic test evaluates the GATAD2B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 18 (MRD18).
TEST-6112 GATM Gene (Arginine:Glycine Amidinotransferase [AGAT] Deficiency) Genetic Test This test identifies pathogenic variants in the GATM gene responsible for arginine:glycine amidinotransferase (AGAT) deficiency.	Peripheral whole blood (3–5 mL EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GATM gene", "Full gene coverage including exons, splice sites, and regulatory regions"] Parameters [] Preparation ["No fasting required", "Avoid recent blood transfusions (within 2 weeks)", "Avoid use of certain anti-metabolites or creatine supplements (consult genetic counsellor for washout guidance)"] Indications ["Suspected AGAT deficiency based on clinical presentation", "Confirmation of diagnosis in individuals with biochemical abnormalities (e.g., elevated guanidinoacetate)", "Family screening for carriers or affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 50398-7 ICD-10: E72.8 Clinical summary This test identifies pathogenic variants in the GATM gene responsible for arginine:glycine amidinotransferase (AGAT) deficiency.
TEST-6091 GBE1 Gene (Andersen Disease) Genetic Test This genetic test identifies pathogenic variants in the GBE1 gene associated with Andersen disease (glycogen storage disease type IV).	Whole Blood (EDTA), Extracted DNA, or FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GBE1 gene", "Presence of mutations causing Andersen disease"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected Andersen disease based on clinical presentation", "Family history of glycogen storage disease type IV", "Carrier screening in relatives of affected individuals", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E74.09, Z15.89, Z13.228 Clinical summary This genetic test identifies pathogenic variants in the GBE1 gene associated with Andersen disease (glycogen storage disease type IV).
TEST-3754 GFAP Gene Alexander Disease Genetic Test This test evaluates the entire GFAP gene for mutations associated with Alexander disease.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No fasting required", "No medication changes necessary unless instructed"] Indications ["Clinical suspicion of Alexander disease", "Family history of Alexander disease", "Infantile macrocephaly with progressive spasticity and ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 92550-1 ICD-10: G31.89 Clinical summary This test evaluates the entire GFAP gene for mutations associated with Alexander disease.
TEST-6223 GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test This genetic test identifies disease-causing variants in the GFM1 gene associated with combined oxidative phosphorylation deficiency type 1.	Peripheral Whole Blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GFM1 gene", "Single-nucleotide variants", "Copy-number variants"] Parameters [] Preparation [] Indications ["Diagnosis of combined oxidative phosphorylation deficiency type 1", "Carrier screening in at-risk families", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 101447-4 ICD-10: E88.49 Clinical summary This genetic test identifies disease-causing variants in the GFM1 gene associated with combined oxidative phosphorylation deficiency type 1.
TEST-2571 GFM2 Gene Microcephaly with Simplified Gyral Pattern and Insulin‑Dependent Diabetes Genetic Test This genetic test identifies pathogenic variants in the GFM2 gene associated with microcephaly with simplified gyral pattern and insulin-dependent diabetes.	Whole Blood (EDTA) or FTA Card (DNA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GFM2 gene"] Parameters [] Preparation ["No specific fasting required", "Avoid sample contamination"] Indications ["Suspected GFM2-related syndrome", "Microcephaly with simplified gyral pattern", "Early-onset insulin-dependent diabetes"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q02, E10.9, Z15.89 Clinical summary This genetic test identifies pathogenic variants in the GFM2 gene associated with microcephaly with simplified gyral pattern and insulin-dependent diabetes.
TEST-2811 GHR Gene Analysis (Growth Hormone Insensitivity, Partial) Test This test evaluates the GHR gene for pathogenic variants associated with partial growth hormone insensitivity (Laron syndrome). It helps identify the genetic cause of the condition...	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GHR gene sequence variants", "Copy Number Variations (CNV) in GHR gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Children with unexplained short stature", "Delayed growth", "Family history of Laron syndrome", "Evaluation of growth failure despite normal GH levels"] Measurement technique Confirm with laboratory Codes LOINC: 21662-6 ICD-10: E34.3, E23.0 Clinical summary This test evaluates the GHR gene for pathogenic variants associated with partial growth hormone insensitivity (Laron syndrome). It helps identify the genetic cause of the condition.
TEST-3785 GHRHR Gene Growth Hormone Deficiency Genetic Test This test detects pathogenic variants in the GHRHR gene associated with isolated growth hormone deficiency type IB.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks from sample receipt in laboratory	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in GHRHR gene", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number alterations"] Parameters [] Preparation [] Indications ["Diagnosis of isolated growth hormone deficiency type IB", "Guiding targeted endocrine therapy", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81343-6 ICD-10: E23.0 Clinical summary This test detects pathogenic variants in the GHRHR gene associated with isolated growth hormone deficiency type IB.
TEST-5610 GJB2 Gene (KID Syndrome) Genetic Test This test evaluates the GJB2 gene for pathogenic variants associated with Keratitis-Ichthyosis-Deafness (KID) syndrome.	Whole Blood (EDTA), Extracted DNA (≥1 µg), or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GJB2 gene coding region", "GJB2 gene splice sites"] Parameters [] Preparation [] Indications ["Suspected KID syndrome based on clinical presentation", "Family history of KID syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21629-6 ICD-10: Q80.8 Clinical summary This test evaluates the GJB2 gene for pathogenic variants associated with Keratitis-Ichthyosis-Deafness (KID) syndrome.
TEST-5552 GJB2 Gene Keratoderma, Palmoplantar, with Deafness Genetic Test This test evaluates the GJB2 gene for pathogenic variants associated with Palmoplantar Keratoderma with Deafness (PPK-D). It identifies mutations causing a syndromic combination of...	Peripheral whole blood (3–5 mL in EDTA tube) or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJB2 gene (Connexin 26)", "Full coding region sequencing", "Deep read depth analysis"] Parameters [] Preparation ["No specific dietary or medication restrictions are required.", "Continue all prescribed medications unless advised otherwise by a specialist.", "Inform the phlebotomist of any anticoagulant therapy."] Indications ["Individuals with clinical features suggestive of PPK-D", "Family history of PPK-D", "Genetic counseling for individuals at risk"] Measurement technique Confirm with laboratory Codes LOINC: 21657-2 ICD-10: Q82.8, H90.5 Clinical summary This test evaluates the GJB2 gene for pathogenic variants associated with Palmoplantar Keratoderma with Deafness (PPK-D). It identifies mutations causing a syndromic combination of thickened palms/soles and sensorineural hearing loss.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.